Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
After-Hours: 20:00
Ambrx Biopharma Cash from Investing (TTM): 62.64M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 62.64M |
June 30, 2023 | 56.22M |
Date | Value |
---|---|
March 31, 2023 | -16.39M |
December 31, 2022 | -46.72M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-46.72M
Minimum
Dec 2022
62.64M
Maximum
Sep 2023
13.94M
Average
19.92M
Median
Cash from Investing (TTM) Benchmarks
Johnson & Johnson | -2.901B |
Axonics Inc | 20.63M |
Harpoon Therapeutics Inc (DELISTED) | 3.283M |
Merck & Co Inc | -13.10B |
RayzeBio inc (DELISTED) | -- |